Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4J3E

The 1.9A crystal structure of humanized Xenopus Mdm2 with nutlin-3a

Summary for 4J3E
Entry DOI10.2210/pdb4j3e/pdb
Related1RV1 4IPF
DescriptorE3 ubiquitin-protein ligase Mdm2, 4-({(4S,5R)-4,5-bis(4-chlorophenyl)-2-[4-methoxy-2-(propan-2-yloxy)phenyl]-4,5-dihydro-1H-imidazol-1-yl}carbonyl)piperazin-2-one, SULFATE ION, ... (4 entities in total)
Functional Keywordsmdm2, protein-protein interaction, imidazoline, ligase-antagonist complex, e3 ubiquitin ligase, p53, nucleus, ligase/antagonist
Biological sourceXenopus laevis (clawed frog,common platanna,platanna)
Cellular locationNucleus, nucleoplasm (By similarity): P56273
Total number of polymer chains1
Total formula weight10640.17
Authors
Graves, B.J.,Lukacs, C.M.,Kammlott, R.U.,Crowther, R. (deposition date: 2013-02-05, release date: 2013-04-24, Last modification date: 2024-02-28)
Primary citationVu, B.,Wovkulich, P.,Pizzolato, G.,Lovey, A.,Ding, Q.,Jiang, N.,Liu, J.J.,Zhao, C.,Glenn, K.,Wen, Y.,Tovar, C.,Packman, K.,Vassilev, L.,Graves, B.
Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development.
ACS Med Chem Lett, 4:466-469, 2013
Cited by
PubMed Abstract: The p53 tumor suppressor is a potent transcription factor that plays a key role in the regulation of cellular responses to stress. It is controlled by its negative regulator MDM2, which binds directly to p53 and inhibits its transcriptional activity. MDM2 also targets p53 for degradation by the proteasome. Many tumors produce high levels of MDM2, thereby impairing p53 function. Restoration of p53 activity by inhibiting the p53-MDM2 interaction may represent a novel approach to cancer treatment. RG7112 (2g) is the first clinical small-molecule MDM2 inhibitor designed to occupy the p53-binding pocket of MDM2. In cancer cells expressing wild-type p53, RG7112 stabilizes p53 and activates the p53 pathway, leading to cell cycle arrest, apoptosis, and inhibition or regression of human tumor xenografts.
PubMed: 24900694
DOI: 10.1021/ml4000657
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.91 Å)
Structure validation

237423

건을2025-06-11부터공개중

PDB statisticsPDBj update infoContact PDBjnumon